Gen-Probe (GPRO) Appoints Carl W. Hull as CEO
Down)
Gen-Probe Incorporated (Nasdaq: GPRO) announced that Carl W. Hull has formally succeeded the Company's long-time leader, Henry L. Nordhoff, as chief executive officer (CEO). Mr. Hull, formerly Gen-Probe's president and chief operating officer, also has joined the Company's board of directors.
As first announced on March 23, Mr. Nordhoff retired as CEO yesterday. Mr. Nordhoff, who had served as Gen-Probe's CEO since 1994, is now non-executive chairman following his re-election to the board at the Company's annual meeting of stockholders last week.
Gen-Probe Incorporated is in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. [SM]
As first announced on March 23, Mr. Nordhoff retired as CEO yesterday. Mr. Nordhoff, who had served as Gen-Probe's CEO since 1994, is now non-executive chairman following his re-election to the board at the Company's annual meeting of stockholders last week.
Gen-Probe Incorporated is in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. [SM]
You May Also Be Interested In
- PCA3 Test Featured at American Urological Association Meeting
- QLT Inc. (QLTI) Issues Response to Nordic Biotech Notification on Board Nominees
- AngioDynamics (ANGO) Appoints George Bourne as Tech Chief
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
